90Y-DOTA-Lanreotide: A potential agent for targeted therapy
β Scribed by U. Pandey; S. Banerjee; A. Mukherjee; H. D. Sarma; M. Venkatesh
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 127 KB
- Volume
- 273
- Category
- Article
- ISSN
- 1588-2780
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract In recent years, there has been dramatic worldwide increase in incidence of malignant melanoma. Although localised disease is often curable by surgical excision, metastatic melanoma is inherently resistant to most treatments. In this context, targeted radionuclide therapy could be an ef
## Abstract Glioblastoma (GBM), the highestβgrade form of gliomas, is the most frequent and the most aggressive. Recently, a subpopulation of cells with stem cells characteristics, commonly named βtumorβinitiating stem cellsβ (TISCs) or βcancer stem cellsβ (CSCs) were identified in GBM. These cells
## Abstract Injection of bulking substances has been introduced as a new therapy to treat urinary incontinence and vesicoureteral reflux. Currently available bulking substances for the injection therapies include liquid or particulated silicone, collagen gel, and polytetrafluoroethylene paste. Howe